Hydration and skin barrier claims testing for cosmetics

Claim validation studies that satisfy retail and regulatory scrutiny

ALS specializes in clinical testing for high-impact categories like anti-aging and skin renewal, helping meet consumer expectations while reducing regulatory risk. We align study design to support market claims such as "reduces appearance of fine lines" or "improves skin texture," delivering ready-to-use reports for leading retailers (Sephora, Ulta, Amazon, QVC, HSN) and global regulators.

ALS’ Clinical workflows prioritize:

• Upfront feasibility assessments to reduce relabeling and launch delays.
• ISO-aligned testing workflows with IRB reviews and clinically trusted, non-invasive methods.
• Submission-ready reports designed to streamline regulatory and retail approvals.
• Diverse test panels to ensure claims resonate across global audiences.

Whether you're finalizing a hero SKU or updating a core line, ALS helps ensure your claims are ready for market—without delay or ambiguity.

What you receive from clinical testing skin hydration and barrier testing

• Hydration time-course (Corneometer®): baseline, 2h, 4h, 8h, 24h (as applicable)
• Barrier performance (TEWL): Tewameter® or Vapometer® for reinforcement/maintenance claims
• Conductivity (Skicon®): commonly used in APAC hydration assessments
• Skin compatibility (pH): product/skin pH context for barrier support
• Clinical grading: dryness, flaking, tactile texture
• Submission-ready report: statistics, graphs, and optional image-ready assets for marketing

Clinical claim support & launch alignment

Hydration skin claim support retailers and investors can trust

• Validates hydration and barrier function claims like “hydrates for 24 hours,” “restores skin barrier,” and “reduces dryness”
• Accepted by Amazon, Sephora, Ulta, QVC, and HSN QA and compliance teams
• Uses non-invasive, standardized tools: Corneometer®, Tewameter®, Skicon®, and pH meters
• Timelines aligned with final formulation and retail launch schedules
• Clinical capacity across U.S. and Latin America for regional and global launches
• Submission-ready reports formatted for use by QA, regulatory, marketing, and investor teams
• Designed to reduce relabeling, regulatory delays, and claim rejection